PFEEarnings ReleaseSource checkedAugust 5, 2026by InvestLog AI

PFE earnings release — EPS beat +12.9% · revenue beat +4.4%Pfizer Inc. (PFE) 财报发布 — EPS 高于预期+12.9% · 营收高于预期+4.4%

Key Results

Pfizer Inc. (PFE) published results at 2026-08-04T07:02:43+00:00.

Actual vs Consensus

EPS: $0.77 vs $0.68 estimate, beat+12.9%.

Revenue: $15.0B vs $14.4B estimate, beat+4.4%.

Profitability and Cash Flow

Period: 2026 Q2

Revenue: $15.0B; YoY: +2.6%; QoQ: +4.0%

Gross profit: $10.9B; Gross margin: 72.8%

Operating income: $4.7B; Operating margin: 31.3%; YoY: +31.6%; QoQ: +16.7%

Net income: -$248M; GAAP diluted EPS: $-0.04; YoY: -108.5%; QoQ: -109.2%

Operating cash flow: $835M; Capex: $533M; Free cash flow: $302M

Cash: $976M; Total debt: $63.2B; Net debt: $62.2B

Forward Guidance

FY2026 revenue $60.5–62.5B; adjusted diluted EPS $2.80–$3.00.

Official release: Reports Second-Quarter Results

核心结果

Pfizer Inc. (PFE) 已发布财报，发布时间：2026-08-04T07:02:43+00:00。

实际值与市场预期

EPS：$0.77 vs $0.68 预期，高于预期+12.9%。

营收：$15.0B vs $14.4B 预期，高于预期+4.4%。

财务指标

期间：2026 Q2

营收：$15.0B；同比：+2.6%；环比：+4.0%

毛利润：$10.9B；毛利率：72.8%

经营利润：$4.7B；经营利润率：31.3%；同比：+31.6%；环比：+16.7%

净利润：-$248M；GAAP 稀释 EPS：$-0.04；同比：-108.5%；环比：-109.2%

经营现金流：$835M；资本开支：$533M；自由现金流：$302M

现金：$976M；总债务：$63.2B；净债务：$62.2B

前瞻指引

2026 年营收指引 605亿–625亿美元；调整后稀释 EPS 2.80–3.00 美元。

官方公告：Reports Second-Quarter Results

View PFE stock details ->查看 PFE 个股详情 ->

This earnings research was prepared from company results, regulatory filings, financial statements, and earnings-call transcripts or official replays. It is for informational purposes only and does not constitute investment advice.这篇财报研究基于公司业绩公告、监管文件、财务报表，以及财报电话会议记录或官方回放整理。内容仅供参考，不构成投资建议。

PFE earnings release — EPS beat +12.9% · revenue beat +4.4%Pfizer Inc. (PFE) 财报发布 — EPS 高于预期+12.9% · 营收 高于预期+4.4%